CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT) | |
CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT | |
212138
OMIM = Online Mendelian Inheritance of Men | |
159 | |
Mitochondrial carnitine/acylcarnitine carrier protein | |
--- | |
3p21.31 Detail information to gene locus by the National Center for Biotechnology Information NCBI: |
|
E71.3 | |
rare autosomal recessive mutation in the SLC25A20 failure to transport long chain acylcarnitines to the mitochondria | |
Laboratory findings | Acylcarnitine (C2) inc (urine) Adipic acid inc (urine) Ammonia inc (blood) Carnitine-acylcarnitine translocase dec (fibroblasts) D-Glucose dec (blood) Dicarboxylic acids normal/inc (urine) L-Carnitine dec (plasma) L-Carnitine dec (serum) L-Lactic acid inc (blood) Linoleoylcarnitine (C18:2) inc (plasma) Oleoylcarnitine (C18:1) inc (plasma) Palmitoylcarnitine (C16) inc (plasma) Sebacic acid inc (urine) Stearoylcarnitine (C18) inc (plasma) Suberic acid inc (urine) Tetradecanoylcarnitine (C14) inc (dried blood spot (DB) |
Symptoms | cardiac arrhythmia, dysrhythmia cardiomyopathy coma early death encephalopathy hypotonia lethargy, drowsiness, apathy liver involvement or dysfunction myopathy cardiac arrest cardiomyopathy, dilated cardiomyopathy, mixed type hepatomegaly (large liver) hyperammonemia hypoglycemia hypothermia lactic acidosis liver failure muscle weakness onset, infancy onset, neonatal Organic acids, urine respiratory distress seizures vomiting |